The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Hypoxia-Induced Lysyl Oxidase Is a Critical Mediator of Bone Marrow Cell Recruitment to Form the Premetastatic Niche
Open accessAbstract
Tumor cell metastasis is facilitated by "premetastatic niches" formed in destination organs by invading bone marrow-derived cells (BMDCs). Lysyl oxidase (LOX) is critical for premetastatic niche formation. LOX secreted by hypoxic breast tumor cells accumulates at premetastatic sites, crosslinks collagen IV in the basement membrane, and is essential for CD11b+ myeloid cell recruitment. CD11b+ cells adhere to crosslinked collagen IV and produce matrix metalloproteinase-2, which cleaves collagen, enhancing the invasion and recruitment of BMDCs and metastasizing tumor cells. LOX inhibition prevents CD11b+ cell recruitment and metastatic growth. CD11b+ cells and LOX also colocalize in biopsies of human metastases. Our findings demonstrate a critical role for LOX in premetastatic niche formation and support targeting LOX for the treatment and prevention of metastatic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Specifically, hypoxia-induced lysyl oxidase contributes to the pre-metastatic niche in a process that includes collagen crosslinking and recruitment of CD11b + myeloid cells (Erler et al., 2009).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Erler et al., 2009
In the citing paper
“The BMDCs promote metastasis by producing chemokines that recruit tumor cells to the lung by mechanisms that include stimulation of tumor cell extravasation”
From Hypoxic control of metastasis (2016) · cites this paper as [92]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
Self-citationRetractedHanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Jemal, A., Siegel, R. L., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,184
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Cancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,333
Tensional homeostasis and the malignant phenotype
Paszek, M. J., Zahir, N., Johnson, K. R., Lakins, J. N., Rozenberg, G. I., Gefen, A., Reinhart-King, C. A., Margulies, S. S., Dembo, M., Boettiger, D., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.010 · Cited by 3,941
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J. S., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,677
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Hockel, M., & Vaupel, P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.266 · Cited by 2,662 · cited 1×
“Increased metastases, enhanced tumor progression, and decreased patient survival have been associated with primary tumors that contain large numbers of poorly oxygenated (hypoxic) tumor cells (Cairns et al., 2003; Hockel and Vaupel, 2001; Pouyssegur et al., 2006).”
Background
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 999
In vivomodels in breast cancer research: progress, challenges and future directions
Holen, I., Speirs, V., Morrissey, B., & Blyth, K. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.028274 · Cited by 183
The relevance of the TGF-β Paradox to EMT-MET programs
Morrison, C. D., Parvani, J. G., & Schiemann, W. P. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.02.048 · Cited by 192
Hypoxia-inducible factors and innate immunity in liver cancer
Yuen, V. W., & Wong, C. C. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137553 · Cited by 187
The pro-tumorigenic host response to cancer therapies
Shaked, Y. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0209-6 · Cited by 185
Role of the VEGF/VEGFR Axis in Cancer Biology and Therapy
Rapisarda, A., & Melillo, G. (2012) · Advances in cancer research · doi:10.1016/b978-0-12-386503-8.00006-5 · Cited by 186
Emerging targeted agents in metastatic breast cancer
Zardavas, D., Baselga, J. M., & Piccart, M. J. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.29 · Cited by 184
Distinct Functions of Neutrophil in Cancer and Its Regulation
Granot, Z., & Jabłońska, J. (2015) · Mediators of Inflammation · doi:10.1155/2015/701067 · Cited by 181
Dormant tumour cells, their niches and the influence of immunity
Goddard, E. T., Božić, I., Riddell, S. R., & Ghajar, C. M. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0214-0 · Cited by 180
Pez, F., Dayan, F., Durivault, J., Kaniewski, B., Aimond, G., Provost, G. S. L., Deux, B., Clézardin, P., Sommer, P., Pouysségur, J., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1516 · Cited by 179
Myeloid‐derived suppressor cells: Important contributors to tumor progression and metastasis
Safarzadeh, E., Orangi, M., Mohammadi, H., Babaie, F., & Baradaran, B. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26075 · Cited by 177
Molecular Pathways: Connecting Fibrosis and Solid Tumor Metastasis
Cox, T. R., & Erler, J. T. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1059 · Cited by 179
Self-citationOvercoming disappointing results with antiangiogenic therapy by targeting hypoxia
Rapisarda, A., & Melillo, G. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.64 · Cited by 178
ZMYND8 acetylation mediates HIF-dependent breast cancer progression and metastasis
Chen, Y., Zhang, B., Bao, L., Jin, L., Yang, M., Peng, Y., Kumar, A., Wang, J. E., Wang, C., Zou, X., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95089 · Cited by 176
Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis
Jubb, A. M., Buffa, F. M., & Harris, A. L. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00944.x · Cited by 175
Are Integrins Still Practicable Targets for Anti-Cancer Therapy?
Alday-Parejo, B., Stupp, R., & Rüegg, C. (2019) · Cancers · doi:10.3390/cancers11070978 · Cited by 181
Cell adhesion molecules and their relation to (cancer) cell stemness
Farahani, E., Patra, H. K., Jangamreddy, J. R., Rashedi, I., Kawalec, M., Pariti, R. K. R., Batakis, P., & Wiecheć, E. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu045 · Cited by 180
Lysyl Oxidase, a Targetable Secreted Molecule Involved in Cancer Metastasis
Cox, T. R., Gartland, A., & Erler, J. T. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2306 · Cited by 174
Self-citationMetastatic niche functions and therapeutic opportunities
Celià-Terrassa, T., & Kang, Y. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0145-9 · Cited by 174
The role of extracelluar matrix in osteosarcoma progression and metastasis
Cui, J., Dean, D. C., Hornicek, F. J., Chen, Z., & Duan, Z. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01685-w · Cited by 174
From transformation to metastasis: deconstructing the extracellular matrix in breast cancer
Kaushik, S., Pickup, M. W., & Weaver, V. M. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9650-0 · Cited by 174
Kaelin, W. G. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010975 · Cited by 161
In vivo capture and label-free detection of early metastatic cells
Azarin, S. M., Yi, J., Gower, R. M., Aguado, B. A., Sullivan, M. E., Goodman, A. G., Jiang, E. J., Rao, S. S., Ren, Y., Tucker, S. L., et al. (2015) · Nature Communications · doi:10.1038/ncomms9094 · Cited by 164
New insights into the mechanisms of organ-specific breast cancer metastasis
Lorusso, G., & Rüegg, C. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.03.007 · Cited by 169
Hypoxia and loss of PHD2 inactivate stromal fibroblasts to decrease tumour stiffness and metastasis
Madsen, C. D., Pedersen, J. T., Venning, F. A., Singh, L. B., Moeendarbary, E., Charras, G., Cox, T. R., Sahai, E., & Erler, J. T. (2015) · The EMBO Reports · doi:10.15252/embr.201540107 · Cited by 157
Self-citationMoreno‐Bueno, G., Salvador, F., Martín, A., Floristán, A., Cuevas, E. P., Santos, V., Montes, A., Morales, S., Castilla, M. Á., Rojo‐Sebastián, A., et al. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100156 · Cited by 166
The role of tumour-associated macrophages in bone metastasis
Sousa, S., & Määttä, J. A. (2016) · Journal of bone oncology · doi:10.1016/j.jbo.2016.03.004 · Cited by 158
Ghosh, S., Ghosal, K., Mohammad, S. A., & Sarkar, K. (2019) · Chemical Engineering Journal · doi:10.1016/j.cej.2019.05.023 · Cited by 162
Lysyl Oxidase Plays a Critical Role in Endothelial Cell Stimulation to Drive Tumor Angiogenesis
Baker, A., Bird, D., Welti, J. C., Gourlaouen, M., Lang, G., Murray, G. I., Reynolds, A. R., Cox, T. R., & Erler, J. T. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2447 · Cited by 157
Self-citationTGF-β Signaling in Myeloid Cells Is Required for Tumor Metastasis
Pang, Y., Gara, S. K., Achyut, B. R., Li, Z., Yan, H. H., Day, C., Weiss, J. M., Trinchieri, G., Morris, J. C., & Li, Y. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0527 · Cited by 160
Bui, B. P., Nguyen, P. L., Lee, K., & Cho, J. (2022) · Cancers · doi:10.3390/cancers14246054 · Cited by 178
Bhat, A. A., Yousuf, P., Wani, N. A., Rizwan, A., Chauhan, S. S., Siddiqi, M. A., Bedognetti, D., El-Rifai, W. M., Frenneaux, M. P., Batra, S. K., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00419-w · Cited by 157
The autophagic tumor stroma model of cancer or “battery-operated tumor growth”
Martinez‐Outschoorn, U., Whitaker‐Menezes, D., Pavlides, S., Chiavarina, B., Bonuccelli, G., Trimmer, C., Tsirigos, A., Migneco, G., Witkiewicz, A. K., Balliet, R. M., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.21.13817 · Cited by 158
Molecular Pathways: YAP and TAZ Take Center Stage in Organ Growth and Tumorigenesis
Piccolo, S., Cordenonsi, M., & Dupont, S. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3172 · Cited by 157
The Microenvironment of Lung Cancer and Therapeutic Implications
Mittal, V., Rayes, T. E., Narula, N., McGraw, T. E., Altorki, N. K., & Barcellos‐Hoff, M. H. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-24932-2_5 · Cited by 154
Giles, A. J., Reid, C. M., Evans, J. D., Murgai, M., Vicioso, Y. M., Highfill, S. L., Kasai, M., Vahdat, L. T., Mackall, C. L., Lyden, D. C., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-0204 · Cited by 161
Comito, G., Calvani, M., Giannoni, E., Bianchini, F., Calorini, L., Torre, E., Migliore, C., Giordano, S., & Chiarugi, P. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.05.042 · Cited by 157
Blockhuys, S., Zhang, X., & Wittung-Stafshede, P. E. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1910722117 · Cited by 153
Shaping Up the Tumor Microenvironment With Cellular Fibronectin
Efthymiou, G., Saint, A., Ruff, M., Rekad, Z., Ciais, D., & Obberghen‐Schilling, E. V. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00641 · Cited by 160
Altea‐Manzano, P., Doglioni, G., Liu, Y., Cuadros, A. M., Nolan, E., Fernández-García, J., Wu, Q., Planque, M., Laue, K., Cidre‐Aranaz, F., et al. (2023) · Nature Cancer · doi:10.1038/s43018-023-00513-2 · Cited by 158
Servais, C., & Erez, N. (2012) · The Journal of Pathology · doi:10.1002/path.4103 · Cited by 161
McDonald, P. C., Chafe, S. C., & Dedhar, S. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00027 · Cited by 154
Lysyl Oxidase–like Protein LOXL2 Promotes Lung Metastasis of Breast Cancer
Salvador, F., Martín, A. L., López‐Menéndez, C., Moreno‐Bueno, G., Santos, V., Vázquez-Naharro, A., Santamarı́a, P. G., Morales, S., Dubus, P. R., Muinelo‐Romay, L., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3152 · Cited by 152
Building the niche: The role of the S100 proteins in metastatic growth
Lukanidin, E. M., & Sleeman, J. P. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.02.006 · Cited by 152
Chitty, J. L., Yam, M., Perryman, L., Parker, A. L., Skhinas, J. N., Setargew, Y. F. I., Mok, E. T. Y., Tran, E., Grant, R. D., Latham, S. L., et al. (2023) · Nature Cancer · doi:10.1038/s43018-023-00614-y · Cited by 154
Neutrophils in Physiology and Pathology
Aroca-Crevillén, A., Vicanolo, T., Ovadia, S., & Hidalgo, A. (2024) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-051222-015009 · Cited by 159
Wu, C., Andzinski, L., Kasnitz, N., Kröger, A., Klawonn, F., Lienenklaus, S., Weiß, S., & Jabłońska, J. (2015) · International Journal of Cancer · doi:10.1002/ijc.29444 · Cited by 154
Do all roads lead to Rome? Routes to metastasis development
Sleeman, J. P., Nazarenko, I. A., & Thiele, W. (2011) · International Journal of Cancer · doi:10.1002/ijc.26027 · Cited by 153
Meeting the Challenge of Targeting Cancer Stem Cells
Turdo, A., Veschi, V., Gaggianesi, M., Chinnici, A., Bianca, P., Todaro, M., & Stassi, G. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00016 · Cited by 155
Hypoxia, HIFs and bone development
Araldi, E., & Schipani, E. (2010) · Bone · doi:10.1016/j.bone.2010.04.606 · Cited by 153
Eyre, R., Alférez, D., Santiago-Gómez, A., Spence, K., McConnell, J. C., Hart, C. A., Simões, B. M., Lefley, D. V., Tulotta, C., Storer, J. A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12807-0 · Cited by 150
Hypoxia-Driven Effects in Cancer: Characterization, Mechanisms, and Therapeutic Implications
Shi, R., Liao, C., & Zhang, Q. H. (2021) · Cells · doi:10.3390/cells10030678 · Cited by 151
Human copper-dependent amine oxidases
Finney, J., Moon, H.-J., Ronnebaum, T. A., Lantz, M., & Mure, M. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2013.12.022 · Cited by 153
Dynamic matrisome: ECM remodeling factors licensing cancer progression and metastasis
Yuzhalin, A. E., Lim, S. Y., Kutikhin, A. G., & Gordon-Weeks, A. N. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.09.002 · Cited by 147
Connections between the cell cycle, cell adhesion and the cytoskeleton
Jones, M., Zha, J., & Humphries, M. J. (2019) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2018.0227 · Cited by 144
Hypoxia in solid tumors: a key promoter of cancer stem cell (CSC) resistance
Najafi, M., Farhood, B., Mortezaee, K., Kharazinejad, E., Majidpoor, J., & Ahadi, R. (2019) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-019-03080-1 · Cited by 151
Chen, X., & Song, E. (2022) · 癌症:英文版 · doi:10.1002/cac2.12316 · Cited by 151
New insights into the correlations between circulating tumor cells and target organ metastasis
Zhan, Q., Liu, B., Situ, X., Luo, Y., Fu, T., Wang, Y., Xie, Z., Ren, L., Zhu, Y. J., He, W., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01725-9 · Cited by 156
Wu, S., Zheng, Q., Xing, X., Dong, Y., Wang, Y., You, Y., Chen, R., Hu, C., Chen, J., Gao, D., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0761-z · Cited by 143
Immune regulation of metastasis: mechanistic insights and therapeutic opportunities
Blomberg, O. S., Spagnuolo, L., & de Visser, K. E. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.036236 · Cited by 145
González, J., Villalba‐Orero, M., Busnadiego, Ó., López-Olañeta, M. M., Sandoval, P., Snabel, J. M., López‐Cabrera, M., Erler, J. T., Hanemaaijer, R., Lara‐Pezzi, E., et al. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv214 · Cited by 142
Self-citationA Stiff Blow from the Stroma: Collagen Crosslinking Drives Tumor Progression
Ng, M. R., & Brugge, J. S. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.11.013 · Cited by 142
Roles of p38 MAPKs in invasion and metastasis
Barrantes, I. D. B., & Nebreda, Á. R. (2012) · Biochemical Society Transactions · doi:10.1042/bst20110676 · Cited by 144
Deregulation of FoxM1b leads to tumour metastasis
Park, H. J., Gusarova, G. A., Wang, Z., Carr, J. R., Li, J., Kim, K., Qiu, J., Park, Y., Williamson, P. R., Hay, N., et al. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000107 · Cited by 143
Role of the hypoxic tumor microenvironment in the resistance to anti-angiogenic therapies
Rapisarda, A., & Melillo, G. (2009) · Drug Resistance Updates · doi:10.1016/j.drup.2009.03.002 · Cited by 142
Hsp47 promotes cancer metastasis by enhancing collagen-dependent cancer cell-platelet interaction
Xiong, G., Chen, J., Zhang, G., Wang, S., Kawasaki, K., Zhu, J., Zhang, Y., Nagata, K., Li, Z., Zhou, B. P., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1911951117 · Cited by 145
The secretome in cancer progression
Paltridge, J. L., Belle, L., & Khew‐Goodall, Y. (2013) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2013.03.014 · Cited by 145
microRNA-mediated regulation of the tumor microenvironment
Chou, J., Shahi, P., & Werb, Z. (2013) · Cell Cycle · doi:10.4161/cc.26087 · Cited by 141
Yousefi, M., Nosrati, R., Salmaninejad, A., Dehghani, S., Shahryari, A., & Saberi, A. (2018) · Cellular Oncology · doi:10.1007/s13402-018-0376-6 · Cited by 143
Interactions in the (Pre)metastatic Niche Support Metastasis Formation
Doglioni, G., Parik, S., & Fendt, S. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00219 · Cited by 142
Hill, B. S., Sarnella, A., D’Avino, G., & Zannetti, A. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.028 · Cited by 142
Zhong, Q., Fang, Y., Lai, Q., Wang, S., He, C., Li, A., Liu, S., & Yan, Q. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01637-4 · Cited by 141
Shibue, T., & Weinberg, R. A. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.12.003 · Cited by 138
Hurst, D. R., & Welch, D. R. (2011) · International review of cytology · doi:10.1016/b978-0-12-385859-7.00003-3 · Cited by 140
Park, K. C., Fouani, L., Jansson, P. J., Wooi, D., Sahni, S., Lane, D. J. R., Palanimuthu, D., Lok, H. C., Kovačević, Ž., Huang, M., et al. (2016) · Metallomics · doi:10.1039/c6mt00105j · Cited by 139
Hypoxia-induced metastasis model in embryonic zebrafish
Rouhi, P., Jensen, L. D., Cao, Z., Hosaka, K., Länne, T., Wahlberg, E., Steffensen, J. F., & Cao, Y. (2010) · Nature Protocols · doi:10.1038/nprot.2010.150 · Cited by 136
Chafe, S. C., Lou, Y., Sceneay, J., Vallejo, M., Hamilton, M. J., McDonald, P. C., Bennewith, K. L., Möller, A., & Dedhar, S. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3000 · Cited by 136
Self-citationEngineered Culture Models for Studies of Tumor-Microenvironment Interactions
Infanger, D. W., Lynch, M. E., & Fischbach, C. (2013) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071811-150028 · Cited by 133
Catena, R., Bhattacharya, N., Rayes, T. E., Wang, S., Choi, H., Gao, D., Ryu, S., Joshi, N., Bielenberg, D. R., Lee, S. B., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0476 · Cited by 132
BMP4 Inhibits Breast Cancer Metastasis by Blocking Myeloid-Derived Suppressor Cell Activity
Cao, Y., Slaney, C. Y., Bidwell, B. N., Parker, B. S., Johnstone, C. N., Rautela, J., Eckhardt, B. L., & Anderson, R. L. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3171 · Cited by 135
Lin, Z., Luo, G., Du, W., Kong, T., Liu, C., & Liu, Z. (2019) · Small · doi:10.1002/smll.201903899 · Cited by 134
Bedogni, B., & Powell, M. B. (2009) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2009.00553.x · Cited by 136
Lysyl Oxidase Isoforms and Potential Therapeutic Opportunities for Fibrosis and Cancer
Trackman, P. C. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1151003 · Cited by 133
Avraham, H. K., Jiang, S., Fu, Y., Nakshatri, H., Ovadia, H., & Avraham, S. (2013) · The Journal of Pathology · doi:10.1002/path.4304 · Cited by 127
Carcinoma-associated fibroblasts provide operational flexibility in metastasis
Wever, O. D., Bockstal, M. V., Mareel, M., Hendrix, A., & Bracke, M. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.12.009 · Cited by 137
Hiratsuka, S., Ishibashi, S., Tomita, T., Watanabe, A., Akashi‐Takamura, S., Murakami, M., Kijima, H., Miyake, K., Aburatani, H., & Maru, Y. (2013) · Nature Communications · doi:10.1038/ncomms2856 · Cited by 127
Function of cancer cell-derived extracellular matrix in tumor progression
Xiong, G., & Xu, R. (2016) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2016.08 · Cited by 129
Jaiswal, R., & Sedger, L. M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00125 · Cited by 140
Mujčić, H., Nagelkerke, A., Rouschop, K. M. A., Chung, S., Chaudary, N., Span, P. N., Clarke, B. A., Milosevic, M., Sykes, J. R., Hill, R. P., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0526 · Cited by 130
Ju, J. A., Godet, I., Ye, I. C., Byun, J., Jayatilaka, H., Lee, S. J., Xiang, L., Samanta, D., Lee, M., Wu, P.-H., et al. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0338 · Cited by 128
Distant Relations: Macrophage Functions in the Metastatic Niche
Doak, G. R., Schwertfeger, K. L., & Wood, D. K. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.03.011 · Cited by 130
Mehraj, U., Ganai, R. A., Macha, M. A., Hamid, A., Zargar, M. A., Bhat, A. A., Nasser, M. W., Haris, M., Batra, S. K., Alshehri, B., et al. (2021) · Cellular Oncology · doi:10.1007/s13402-021-00634-9 · Cited by 128
COMMD1 disrupts HIF-1α/β dimerization and inhibits human tumor cell invasion
van de Sluis, B., Mao, X., Zhai, Y., Groot, A. J., Vermeulen, J. F., van der Wall, E., van Diest, P. J., Hofker, M. H., Wijmenga, C., Klomp, L. W. J., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40583 · Cited by 132
The potential role of HIF on tumour progression and dissemination
Unwith, S., Zhao, H., Hennah, L., & Ma, D. (2014) · International Journal of Cancer · doi:10.1002/ijc.28889 · Cited by 130
Engineering the pre-metastatic niche
Aguado, B. A., Bushnell, G. G., Rao, S. S., Jeruss, J. S., & Shea, L. D. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0077 · Cited by 131
Relationship between copper and immunity: The potential role of copper in tumor immunity
Cheng, F., Peng, G., Lu, Y., Wang, K., Ju, Q., Ju, Y., & Ouyang, M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1019153 · Cited by 128
Extracellular Matrix Remodeling and Stiffening Modulate Tumor Phenotype and Treatment Response
Leight, J. L., Drain, A. P., & Weaver, V. M. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-050216-034431 · Cited by 131
Zhao, T., Zhu, Y., Morinibu, A., Kobayashi, M., Shinomiya, K., Itasaka, S., Yoshimura, M., Guo, G., Hiraoka, M., & Harada, H. (2014) · Scientific Reports · doi:10.1038/srep03793 · Cited by 122
Zhao, C., Wang, X., Zhao, Y., Li, Z., Lin, S., Wei, Y., & Yang, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021768 · Cited by 123
Tumor-Secreted LOXL2 Activates Fibroblasts through FAK Signaling
Barker, H. E., Bird, D., Lang, G., & Erler, J. T. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0033-t · Cited by 119
Self-citationCancer Metastasis: A Reappraisal of Its Underlying Mechanisms and Their Relevance to Treatment
Riggi, N., Aguet, M., & Stamenkovic, I. (2017) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-044127 · Cited by 121
Metadata
- Authors
- Erler, J. T., Bennewith, K. L., Cox, T. R., Lang, G., Bird, D., Koong, A., Le, Q.-T., & Giaccia, A. J.
- Affiliations
- Institute of Cancer Research (GB)
- BC Cancer Agency (CA)
- Stanford Medicine (US)
- Corresponding author
- Giaccia, Amato J.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2009-01
- Volume
- 15
- Issue
- 1
- Pages
- 35-44
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC3050620
- OpenAlex
- W2159744630
- Cited by
- 1,231
- References
- 40
- Citations by year
- 2026: 38 · 2025: 45 · 2024: 61 · 2023: 66 · 2022: 62 · 2021: 82 · 2020: 78 · 2019: 96 · 2018: 80 · 2017: 71 · 2016: 90 · 2015: 72 · 2014: 74 · 2013: 87 · 2012: 72
- FWCI
- 37.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Cancer Research UK
- National Cancer Institute (P01CA067166, T32CA009151)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- lysyl oxidase, pre-metastatic niche, metastasis, bone marrow-derived cells, hypoxia, breast cancer, CD11b+ myeloid cells, basement membrane, MMP-2, collagen degradation, metastasis prevention
- MeSH terms
- Animals, Hypoxia, Basement Membrane, Bone Marrow Cells, Breast Neoplasms, Cell Differentiation, Cell Movement, Cell Separation, Enzyme Activation, Humans, Lung Neoplasms, Protein-Lysine 6-Oxidase, Mice, Nude, Neoplasm Metastasis, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Disease Progression, Matrix Metalloproteinase 2, Myeloid Cells, Xenograft Model Antitumor Assays, Collagen Type IV, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review